Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Article in Frontiers in Cardiovascular Medicine (September 2022)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
Article in Kidney International Reports (May 2022)
Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation
Article in PLOS ONE (March 2021)